Govt faces calls to compensate women affected by mesh scandal
The government has been urged to give financial compensation to women affected by the mesh scandal - as the patient safety commissioner said she was disappointed by the "silence" victims say they have faced.
Dr Henrietta Hughes highlighted in a report last year that thousands of women's lives were "destroyed" and that there was a "" for thousands of women and children affected by implants and sodium valproate.
She urged ministers to create a two-stage financial redress scheme - an interim scheme and a main scheme as campaigners said they have "faced silence" in the year since the report was published.
"It is very disappointing that women who have suffered so much harm are still waiting for redress," she said.
"This is an injustice as it augments the original harm they suffered. They need redress now and the government must act immediately."
Kath Sansom, founder of the Sling the Mesh campaign group, said that women's lives have been "irreparably damaged" by mesh, with many unable to work or forced to reduce their hours due to chronic pain and disability.
Despite this, no compensation scheme has been put in place to help those affected, Ms Sansom said.
"For a year, we have waited for action, but all we've received is silence," she said.
"The Hughes Report made it clear that financial redress is essential.
"It is unacceptable that the government continues to turn a blind eye to women who have lost their health, their jobs, and their quality of life through no fault of their own.
"The time for excuses is over - we need action now."
Read more:
Transvaginal mesh implants were used to treat pelvic organ prolapse and incontinence after childbirth.
But they have caused debilitating harm to some women.
Side effects have included infection, pelvic pain, difficulty urinating, pain during sex and incontinence.
A Department of Health and Social Care spokesperson said: "The harm caused by sodium valproate and pelvic mesh continues to be felt today. Our sympathies are with those affected and we are fully focused on how best to support patients and prevent future harm.
"This is a complex area of work and health minister Baroness Gillian Merron met with some of those affected before Christmas, and has committed to providing an update to the patient safety commissioner at the earliest opportunity."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 days ago
- Yahoo
Millions more to get test results via NHS app, government says
The NHS app will become the default method of communication for millions more patients in England and save the health service £200m over the next three years, the government has said. More test results, screening invitations and appointment reminders will be sent directly to smartphones as part of a £50m investment in the app, in a move away from traditional communication methods such as letters. It is estimated that at least 50 million letters are sent to patients each year. The Department of Health and Social Care said that people who cannot access app messaging - including elderly patients - will receive text messages and then a letter as a last resort, and NHS phone lines would be freed up. The department says 270 million messages will be sent through the NHS app this financial year - an increase of 70 million on the previous year. Push notifications will provide appointment reminders to patients to try to reduce the risk of no attendance - with around eight million missed appointments in elective care missed in 2023/24. Work is also under way to enable users of the app to add appointments to their phone calendars and request help from their local GP surgeries. Figures show that more than 11 million people in the UK log into the NHS app every month, while almost 20 million are opted in to receive healthcare messages from the app. It is hoped the changes will give patients better access to manage their healthcare journey and make informed decisions about their care. NHS app services, which were launched in December 2018, are now used in 87% of hospitals across England. Health Secretary Wes Streeting said further investment in the app would bring the NHS into the digital age so that being a patient was as "convenient as online banking or ordering a takeaway". He added that moving away from paper communication could free up funding for front line services. Rachel Power, chief executive of the Patient's Association, said the upgrade was a "significant step in modernising how patients receive information". The British Medical Association (BMA) has previously warned that a reliance on apps to the NHS to communicate with patients risked alienating patients who don't have access to digital technology. It followed the government's announcement in January that it planned to allow more patients in England to book treatments and appointments through the app. Last month, NHS England announced millions of patients would be able to get "Amazon-style" tracking updates on their prescriptions through the app, to check if their medicines are ready to collect or have been despatched for delivery. New app trial cuts skin cancer referrals by 50% NHS App upgrade to give patients more choice over treatment Patients to get full access to record on NHS App
Yahoo
6 days ago
- Yahoo
Council gets £10m boost for drug and alcohol support
Lancashire County Council has been handed more than £10m by the government to prevent drug and alcohol-related deaths and help those with addiction issues. The authority said the cash, which has been put together by consolidating other grants for services like recovery programs and housing schemes for vulnerable people, was one of the largest amounts allocated across England. A council spokesperson said it would be used to pay for services like mental health support for those with substance abuse problems and drug education in schools. County Councillor Daniel Matchett, who works as a mental health nurse, said the funding was welcome as he had seen the "devastation" caused by drugs first-hand. Councillors have approved the allocation of the £10m grant by the Department of Health and Social Care. It is aimed at funding improved treatment, cutting crime and preventing drug and alcohol-related deaths. Matchett said: "It is a significant amount of funding. "There is a real focus on improving the quality of treatment and making sure more people can access this, which will help prevent drug and alcohol-related deaths in the county." Among the services that will be supported by the grant are addiction recovery help out-of-hours as well as additional weekend support, and inpatient detox placements. It also includes funding for training to professionals in schools and improved support for those in the criminal justice system. Listen to the best of BBC Radio Lancashire on Sounds and follow BBC Lancashire on Facebook, X and Instagram. You can also send story ideas via Whatsapp to 0808 100 2230. Lancashire County Council
Miami Herald
6 days ago
- Miami Herald
Women on Weight-Loss Drugs Warned of Surprise ‘Ozempic Babies'
Women taking popular weight-loss drugs have been urged to use effective contraception while taking the medication amid reports of a so-called "Ozempic babies" phenomenon. The advice was issued by the United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA), an executive agency of the Department of Health and Social Care, on Thursday. Newsweek reached out to the U.S. Department of Health and Human Services for comment via email. Demand for weight-loss drugs, including GLP-1 medications such as Ozempic, Wegovy, and Mounjaro, has surged in the United States. In May 2024, a KFF Health Tracking Poll found that approximately 6 percent of American adults—about 15 million people—were using GLP-1 agonists such as Ozempic, either for diabetes treatment or weight loss. Some experts have cautioned that women should use effective contraception while taking these medications amid reports that they may be linked to an increase in unexpected pregnancies, The Guardian reported last May. The MHRA issued its alert after receiving 40 reports related to pregnancies while using "GLP-1 medicines," which are known by the brand names Ozempic, Mounjaro, Wegovy, Saxenda, and Victoza. Ozempic and Wegovy contain semaglutide, which mimics the GLP-1 hormone to increase insulin, slow digestion, and suppress appetite. Mounjaro contains tirzepatide, which acts on an additional hormone related to blood sugar and appetite control. The MHRA warned that Mounjaro may reduce the effectiveness of oral contraceptives in people who are overweight. It received 26 pregnancy-related reports for Mounjaro alone. "Therefore, those taking Mounjaro who are overweight and are using an oral form of contraception are advised to also use a non-oral form of contraception," the agency said. "This only applies to those taking Mounjaro and is especially important for the four weeks after starting Mounjaro and after any dose increase." Hundreds of women have shared personal accounts of unplanned pregnancies while using these medications in online groups, including the Facebook group "I got pregnant on Ozempic." "My ozempic baby...I see so many posts about ozempic and asking for "stories or side effects," but I never see anyone warning about pregnancy... lol," one woman shared on Facebook. "If you don't know, I got pregnant on ozempic and so many other women have too..I was on ozempic for 6 weeks & found out I was pregnant. I was so scared, google had me frightened I would miscarry because of the ozempic. I then came across a group called 'I got pregnant on ozempic'. I started reading all of these stories about women fighting infertility and getting pregnant on ozempic." The Food and Drug Administration has not yet issued similar advisories in the United States. MHRA Chief Safety Officer Dr. Alison Cave said: "Skinny jabs are medicines licensed to treat specific medical conditions and should not be used as aesthetic or cosmetic treatments. They are not a quick fix to lose weight, and have not been assessed to be safe when used in this way. "Our guidance offers patients a 'one stop shop' for our up-to-date advice on how to use these powerful medicines safely. "This guidance should not be used as a substitute to reading the patient information leaflet or having a conversation with a healthcare professional as part of the prescribing process." Dr. Ilana Ressler, a reproductive endocrinologist at Illume Fertility, told Interesting Engineering on May 22: "There is this phenomenon of Ozempic what I think what's happening is women who may not have been ovulating before with the improvements that the medication is bringing on, that might be helping them to ovulate more regularly and they might be more likely to conceive while on the medication than not—so it is recommended to avoid pregnancy while taking the medication." Dr. Zuri A. Murrell, in a video on X last year: "There is nothing magical about the medicine that's in Ozempic that helps you get pregnant. But what it does is that a lot of times, when people can't, it's because of a hormone weight imbalance. "And so, when you lose weight, and sometimes when you lose weight rapidly, the hormones and the new you aren't in concert. Or they really are in concert, and guess what can happen, pregnancy. "So, it's not the Ozempic itself, it is actually the balancing out of your hormones. That means that you've lost fat, and that the body actually for you is working like it should. So just remember, Ozempic is not something that somebody takes and 'I'm pregnant.' What it does do is cause your body and hormone level to be more in sync and more likely that you can." It remains unclear whether the FDA will follow the MHRA's lead in issuing similar warnings or guidance on contraception. Related Articles Therapist Asks Who Women 'Want To Be Skinny For'-Her Theory Is Eye-OpeningThe Good Life: Weight Loss Wins, But at What Cost?How Ozempic and Other GLP-1 Drugs Are Eating Away at Body PositivityGen Z Is Leading a New Weight Loss Trend: Ozempic Microdosing 2025 NEWSWEEK DIGITAL LLC.
